CDIO

SEC source: 0001486189-24-000022 · primary_doc.xml · derivative · entry 2

Intrater James · CIK 0001950394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On March 31, 2024, $12,500 in value of RSUs vested and were settled at the price of $1.42, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On January 23, 2024, the reporting person was awarded $50,000 in value of RSUs, $12,500 in value of which vested on March 31, 2024. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on June 30, 2024, $12,500 in value on September30, 2024 and $12,500 in value on December 31, 2024, based on the closing price of the Issuers common stock on the applicable vesting date.

F3 · derivative.expiration_date: On January 23, 2024, the reporting person was awarded $50,000 in value of RSUs, $12,500 in value of which vested on March 31, 2024. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on June 30, 2024, $12,500 in value on September30, 2024 and $12,500 in value on December 31, 2024, based on the closing price of the Issuers common stock on the applicable vesting date.

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-24-000022 · primary_doc.xml · nonDerivative · entry 1

Intrater James · CIK 0001950394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,596

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on March 31, 2024 through the issuance of shares of Common Stock.

SEC source: 0001486189-24-000021 · primary_doc.xml · derivative · entry 2

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2024-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On March 31, 2024, $12,500 in value of RSUs vested and were settled at the price of $1.42, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On January 23, 2024, the reporting person was awarded $50,000 in value of RSUs, $12,500 in value of which vested on March 31, 2024. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on June 30, 2024, $12,500 in value on September30, 2024 and $12,500 in value on December 31, 2024, based on the closing price of the Issuers common stock on the applicable vesting date.

F3 · derivative.expiration_date: On January 23, 2024, the reporting person was awarded $50,000 in value of RSUs, $12,500 in value of which vested on March 31, 2024. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on June 30, 2024, $12,500 in value on September30, 2024 and $12,500 in value on December 31, 2024, based on the closing price of the Issuers common stock on the applicable vesting date.

SEC source: 0001486189-24-000021 · primary_doc.xml · nonDerivative · entry 1

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,596

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on December 31, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-24-000007 · primary_doc.xml · derivative · entry 2

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · Not disclosed shares

Expires 2024-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On January 31, 2024, $2,000 in value of RSUs vested and were settled at the price of $2.18, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $2,000 in value of which vested on January 31, 2024.

F3 · derivative.expiration_date: On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $2,000 in value of which vested on January 31, 2024.

F4 · balance_after: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-24-000007 · primary_doc.xml · nonDerivative · entry 1

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,522

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs), awarded for advisory services, which vested on January 31, 2024 through the issuance of shares of Common Stock.

SEC source: 0001486189-24-000016 · primary_doc.xml · derivative · entry 1

Burton Paul Frederick · CIK 0002006956 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2024-12-31

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the RSU.

F2 · reported_value: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on March 31, 2024; (ii) $12,500 in value on June 30, 2024; (iii) $12,500 in value on September 30, 2024; and (iv) $12,500 in value on December 31, 2024.

F3 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F2 · valueOwnedAfter: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on March 31, 2024; (ii) $12,500 in value on June 30, 2024; (iii) $12,500 in value on September 30, 2024; and (iv) $12,500 in value on December 31, 2024.

SEC source: 0001486189-24-000018 · primary_doc.xml · derivative · entry 1

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2024-12-31

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the RSU.

F2 · reported_value: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on March 31, 2024; (ii) $12,500 in value on June 30, 2024; (iii) $12,500 in value on September 30, 2024; and (iv) $12,500 in value on December 31, 2024.

F3 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F2 · valueOwnedAfter: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on March 31, 2024; (ii) $12,500 in value on June 30, 2024; (iii) $12,500 in value on September 30, 2024; and (iv) $12,500 in value on December 31, 2024.

SEC source: 0001486189-24-000017 · primary_doc.xml · derivative · entry 1

Intrater James · CIK 0001950394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2024-12-31

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the RSU.

F2 · reported_value: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on March 31, 2024; (ii) $12,500 in value on June 30, 2024; (iii) $12,500 in value on September 30, 2024; and (iv) $12,500 in value on December 31, 2024.

F3 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F2 · valueOwnedAfter: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on March 31, 2024; (ii) $12,500 in value on June 30, 2024; (iii) $12,500 in value on September 30, 2024; and (iv) $12,500 in value on December 31, 2024.

SEC source: 0001486189-24-000015 · primary_doc.xml · derivative · entry 1

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2024-12-31

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the RSU.

F2 · reported_value: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on March 31, 2024; (ii) $12,500 in value on June 30, 2024; (iii) $12,500 in value on September 30, 2024; and (iv) $12,500 in value on December 31, 2024.

F3 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F2 · valueOwnedAfter: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on March 31, 2024; (ii) $12,500 in value on June 30, 2024; (iii) $12,500 in value on September 30, 2024; and (iv) $12,500 in value on December 31, 2024.

SEC source: 0001486189-24-000014 · primary_doc.xml · derivative · entry 1

Luqman Elisa V · CIK 0001486189 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 264,832

Underlying: Common Stock · 35,719 shares

Expires 2034-01-23

SEC source: 0001486189-24-000013 · primary_doc.xml · derivative · entry 1

Abdullahi Khullani · CIK 0001950779 · VP of Revenue and Strategy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 304,128

Underlying: Common Stock · 238,128 shares

Expires 2034-01-23

SEC source: 0001486189-24-000012 · primary_doc.xml · derivative · entry 1

Philibert Robert · CIK 0001949924 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 805,465

Underlying: Common Stock · 142,876 shares

Expires 2034-01-23

SEC source: 0001486189-24-000011 · primary_doc.xml · derivative · entry 1

Hosseinion Warren · CIK 0001438327 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 502,195

Underlying: Common Stock · 35,719 shares

Expires 2034-01-23

SEC source: 0001486189-24-000010 · primary_doc.xml · derivative · entry 2

Dogan Timur · CIK 0001950663 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (1)

Disclosed balance after: 1,433,958

Underlying: Common Stock · 476,256 shares

Expires 2034-01-23

F1 · ownership.direct: These securities are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of such securities except to the extent of her actual pecuniary interest therein.

SEC source: 0001486189-24-000010 · primary_doc.xml · derivative · entry 1

Dogan Timur · CIK 0001950663 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 435,467

Underlying: Common Stock · 238,128 shares

Expires 2034-01-23

SEC source: 0001486189-24-000009 · primary_doc.xml · derivative · entry 2

Dogan Meeshanthini · CIK 0001950789 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (1)

Disclosed balance after: 435,467

Underlying: Common Stock · 238,128 shares

Expires 2034-01-23

F1 · ownership.direct: These securities are held by the reporting person's souse. The reporting person disclaims beneficial ownership of such securities except to the extent of her actual pecuniary interest therein.

SEC source: 0001486189-24-000009 · primary_doc.xml · derivative · entry 1

Dogan Meeshanthini · CIK 0001950789 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,433,958

Underlying: Common Stock · 476,256 shares

Expires 2034-01-23

SEC source: 0001486189-24-000005 · primary_doc.xml · derivative · entry 2

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On December 31, 2023, $12,500 in value of RSUs vested and were settled at the price of $2.49, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on December 31, 2023.

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on December 31, 2023.

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan

SEC source: 0001486189-24-000005 · primary_doc.xml · nonDerivative · entry 1

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,793

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on December 31, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-24-000004 · primary_doc.xml · derivative · entry 2

Sim Brandon · CIK 0001813532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On December 31, 2023, $12,500 in value of RSUs vested and were settled at the price of $2.49, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on December 31, 2023.

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on December 31, 2023.

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-24-000004 · primary_doc.xml · nonDerivative · entry 1

Sim Brandon · CIK 0001813532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,793

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on December 31, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-24-000003 · primary_doc.xml · derivative · entry 2

Intrater James · CIK 0001950394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On December 31, 2023, $12,500 in value of RSUs vested and were settled at the price of $2.49, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on December 31, 2023

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on December 31, 2023

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-24-000003 · primary_doc.xml · nonDerivative · entry 1

Intrater James · CIK 0001950394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,793

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on December 31, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-24-000002 · primary_doc.xml · derivative · entry 2

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On December 31, 2023, $12,500 in value of RSUs vested and were settled at the price of $2.49, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on December 31, 2023.

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on December 31, 2023.

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-24-000002 · primary_doc.xml · nonDerivative · entry 1

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,793

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on December 31, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-24-000001 · primary_doc.xml · derivative · entry 4

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On December 31, 2023, $14,500 in value of RSUs vested and were settled at the price of $2.49, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F6 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F5 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs of which $12,500 vested on December 31, 2023.

F5 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs of which $12,500 vested on December 31, 2023.

F6 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-24-000001 · primary_doc.xml · derivative · entry 3

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2024-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On December 31, 2023, $14,500 in value of RSUs vested and were settled at the price of $2.49, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F6 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F4 · derivative.exercise_date: On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $4,000 in value of which vested on December 31, 2023. Subject to continued service with the Issuer on the vesting date, $2,000 in value of RSUs will vest on January 31, 2024.

F4 · derivative.expiration_date: On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $4,000 in value of which vested on December 31, 2023. Subject to continued service with the Issuer on the vesting date, $2,000 in value of RSUs will vest on January 31, 2024.

F6 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-24-000001 · primary_doc.xml · nonDerivative · entry 2

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,605

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents the settlement of RSUs, awarded as director compensation, which vested on December 31, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-24-000001 · primary_doc.xml · nonDerivative · entry 1

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,585

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs), awarded for advisory services, which vested on December 31, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000040 · primary_doc.xml · nonDerivative · entry 1

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,979

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs), awarded for advisory services, which vested on October 31, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000031 · primary_doc.xml · derivative · entry 2

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $12,500 in value of RSUs vested and were settled at the price of $0.34, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023 and $12,500 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on December 31, 2023 based on the closing price of the Issuers common stock on the vesting date.

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023 and $12,500 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on December 31, 2023 based on the closing price of the Issuers common stock on the vesting date.

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000031 · primary_doc.xml · nonDerivative · entry 1

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on September 30, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000030 · primary_doc.xml · derivative · entry 2

Intrater James · CIK 0001950394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $12,500 in value of RSUs vested and were settled at the price of $0.34, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023 and $12,500 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on December 31, 2023 based on the closing price of the Issuers common stock on the vesting date.

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023 and $12,500 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on December 31, 2023 based on the closing price of the Issuers common stock on the vesting date.

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000030 · primary_doc.xml · nonDerivative · entry 1

Intrater James · CIK 0001950394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on September 30, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000029 · primary_doc.xml · derivative · entry 2

Sim Brandon · CIK 0001813532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · 12,500 shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $12,500 in value of RSUs vested and were settled at the price of $0.34, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023 and $12,500 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on December 31, 2023 based on the closing price of the Issuers common stock on the vesting date.

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023 and $12,500 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on December 31, 2023 based on the closing price of the Issuers common stock on the vesting date.

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000029 · primary_doc.xml · nonDerivative · entry 1

Sim Brandon · CIK 0001813532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on September 30, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000035 · primary_doc.xml · derivative · entry 8

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $12,500 in value of RSUs vested and were settled at the price of $0.34 which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.

F7 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F11 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs of which $12,500 vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date.

F11 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs of which $12,500 vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date.

F7 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000035 · primary_doc.xml · derivative · entry 7

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2024-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $2,000 in value of RSUs vested and were settled at the price of $0.34 which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.

F7 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F6 · derivative.exercise_date: On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023, $2,000 in value of which vested on July 31, 2023, $2,000 in value of which vested on August 31, 2023, and $2,000 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on October 31, 2023; (ii) $2,000 in value on November 30, 2023; (iii) $2,000 in value on December 31, 2023; and (iv) $2,000 in value on January 31, 2024.

F6 · derivative.expiration_date: On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023, $2,000 in value of which vested on July 31, 2023, $2,000 in value of which vested on August 31, 2023, and $2,000 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on October 31, 2023; (ii) $2,000 in value on November 30, 2023; (iii) $2,000 in value on December 31, 2023; and (iv) $2,000 in value on January 31, 2024.

F7 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000035 · primary_doc.xml · nonDerivative · entry 4

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,348

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · kind: Represents the settlement of RSUs, awarded as director compensation, which vested on September 30, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000035 · primary_doc.xml · nonDerivative · entry 3

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,583

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Represents the settlement of RSUs, awarded for advisory services, which vested on September 30, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000034 · primary_doc.xml · derivative · entry 2

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $12,500 in value of RSUs vested and were settled at the price of $0.34, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date.

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date.

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000034 · primary_doc.xml · nonDerivative · entry 1

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on September 30, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000032 · primary_doc.xml · derivative · entry 2

Sim Brandon · CIK 0001813532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $12,500 in value of RSUs vested and were settled at the price of $0.34, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date.

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date.

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan

SEC source: 0001486189-23-000032 · primary_doc.xml · nonDerivative · entry 1

Sim Brandon · CIK 0001813532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on September 30, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000033 · primary_doc.xml · derivative · entry 2

Intrater James · CIK 0001950394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $12,500 in value of RSUs vested and were settled at the price of $0.34, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000033 · primary_doc.xml · nonDerivative · entry 1

Intrater James · CIK 0001950394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on September 30, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000027 · primary_doc.xml · nonDerivative · entry 2

Dogan Meeshanthini · CIK 0001950789 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note(3)

Disclosed balance after: 128,345

F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.54 to $0.55 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

F3 · ownership.direct: These securities are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of such securities except to the extent of her actual pecuniary interest therein.

SEC source: 0001486189-23-000026 · primary_doc.xml · nonDerivative · entry 2

Dogan Timur · CIK 0001950663 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,345

F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.54 to $0.55 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

SEC source: 0001486189-23-000035 · primary_doc.xml · derivative · entry 6

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2024-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On August 31, 2023, $2,000 in value of RSUs vested and were settled at the price of $0.5499, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.

F7 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F6 · derivative.exercise_date: On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023, $2,000 in value of which vested on July 31, 2023, $2,000 in value of which vested on August 31, 2023, and $2,000 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on October 31, 2023; (ii) $2,000 in value on November 30, 2023; (iii) $2,000 in value on December 31, 2023; and (iv) $2,000 in value on January 31, 2024.

F6 · derivative.expiration_date: On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023, $2,000 in value of which vested on July 31, 2023, $2,000 in value of which vested on August 31, 2023, and $2,000 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on October 31, 2023; (ii) $2,000 in value on November 30, 2023; (iii) $2,000 in value on December 31, 2023; and (iv) $2,000 in value on January 31, 2024.

F7 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.